BioSite holds the most complete AU/NZ site intelligence. We find the right site in days, not weeks, with verified data and purchasable feasibility reports.
We sit on the Sponsor's side, not the CRO's. We act as your "eyes and ears" on the ground, ensuring ICH E6(R3) compliance and clean, filing-grade data.
A bilingual Melbourne-based team with deep cross-border relationships. We bridge the language and cultural gap between your China HQ and Australian sites.
Australia offers unmatched speed and cost advantages, but local friction often eats those benefits away. Most small, venture-funded China biotechs arrive without a local entity, unfamiliar with TGA/HREC processes, and relying on a CRO they cannot independently check. Lexinto Biosolutions removes this friction, ensuring your study runs cleanly through to data the FDA and NMPA will accept.
